Studies on a combined diphtheria-pertussis-tetanus-poliomyelitis vaccine.
作者信息
SCHUCHARDT L F, MUNOZ J, VERWEY W F
出版信息
Am J Public Health Nations Health. 1960 Mar;50(3 Pt 1):321-8. doi: 10.2105/ajph.50.3_pt_1.321.
Abstract
摘要
相似文献
1
Studies on a combined diphtheria-pertussis-tetanus-poliomyelitis vaccine.
Am J Public Health Nations Health. 1960 Mar;50(3 Pt 1):321-8. doi: 10.2105/ajph.50.3_pt_1.321.
2
Immune response in guinea pigs and monkeys to the individual components of a combined diphtheria-pertussis-tetanus antigen plus poliomyelitis vaccine.
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):473-83. doi: 10.2105/ajph.47.4_pt_1.473.
3
[STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
Pediatria (Napoli). 1963;71:962-7.
4
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
Vaccine. 2014 Jun 30;32(31):3942-9. doi: 10.1016/j.vaccine.2014.05.034. Epub 2014 May 19.
5
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
6
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Vaccine. 2018 Apr 19;36(17):2300-2306. doi: 10.1016/j.vaccine.2018.03.021. Epub 2018 Mar 22.
7
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.
8
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Hum Vaccin Immunother. 2014;10(10):2795-8. doi: 10.4161/21645515.2014.970494.
9
Statement on the recommended use of pentavalent and hexavalent vaccines. An Advisory Committee Statement (ACS).
Can Commun Dis Rep. 2007 Feb 1;33(ACS-1):1-14.
引用本文的文献
1
Serologic Response of Infants to a Multiple Vaccine for Simultaneous Immunization Against Diphtheria, Pertussis, Tetanus, and Polio-myelitis, in Relation to the Presence of Specific Maternal Antibody.
Am J Public Health Nations Health. 1960 Oct;50(10):1529-38. doi: 10.2105/ajph.50.10.1529.
2
RESPONSES OF INFANTS TO DTP-P VACCINE USED IN NINE INJECTION SCHEDULES.
Public Health Rep (1896). 1964 Jul;79(7):585-602.
3
RESPONSE OF CHICKS TO POLIOVIRUS ANTIGENS.
Public Health Rep (1896). 1963 Nov;78(11):1005-9.
本文引用的文献
1
An analysis of the Wilson-Worcester method for determining the median effective dose of pertussis vaccine.
Am J Public Health Nations Health. 1948 Jan;38(1 Pt 1):15-21. doi: 10.2105/ajph.38.1_pt_1.15.
2
A SIMPLIFIED LIQUID CULTURE MEDIUM FOR THE GROWTH OF HEMOPHILUS PERTUSSIS.
J Bacteriol. 1949 Aug;58(2):127-34.
3
Evaluation of the 1954 poliomyelitis vaccine field trial; further studies of results determining the effectiveness of poliomyelitis vaccine (Salk) in preventing paralytic poliomyelitis.
J Am Med Assoc. 1955 Aug 6;158(14):1266-70. doi: 10.1001/jama.1955.02960140028004.
4
An evaluation of the 1954 poliomyelitis vaccine trials.
Am J Public Health Nations Health. 1955 May;45(5 Pt 2):1-63.
5
Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis).
Am J Public Health Nations Health. 1955 Mar;45(3):312-8. doi: 10.2105/ajph.45.3.312.
6
Multiple antigen for immunization against poliomyelitis, diphtheria, pertussis, and tetanus. I. Response of infants and young children to primary immunization: preliminary report.
J Am Med Assoc. 1958 Jun 28;167(9):1103-7. doi: 10.1001/jama.1958.72990260001011.
7
Factors effecting the efficiency of combined prophylactics: effect of poliomyelitis vaccine on diphtheria toxoid.
J Immunol. 1957 Aug;79(2):89-93.
8
Immune response in guinea pigs and monkeys to the individual components of a combined diphtheria-pertussis-tetanus antigen plus poliomyelitis vaccine.
Am J Public Health Nations Health. 1957 Apr;47(4 Pt 1):473-83. doi: 10.2105/ajph.47.4_pt_1.473.
9
The preservation of poliomyelitis vaccine with stabilized merthiolate.
J Lab Clin Med. 1956 Jan;47(1):8-19.
10
Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system.
Am J Hyg. 1954 Sep;60(2):214-30. doi: 10.1093/oxfordjournals.aje.a119714.
Zotero 插件